Renfeng Guo
Fortuna: 3 M $ al 30/09/2026
Fortuna: 3 M $ al 30/09/2026
Renfeng Guo was the founder of InflaRx GmbH, founded in 2007, and served as Chief Scientific Officer from 2009 to 2012.
Dr. Guo is the founder of InflaRx NV, founded in 2007, and holds the title of Executive Director & Chief Scientific Officer since 2007.
Former job includes Associate Professor at the University of Michigan.
Education includes a doctorate from Norman Bethune Medical University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INFLARX N.V. 1,2 % | 18/03/2026 | 1.762.144 ( 1,2 % ) | 3 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INFLARX N.V. | Fundador | 01/12/2007 |
| Empresas | Cargo | Fin |
|---|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
InflaRx GmbH
InflaRx GmbH BiotechnologyHealth Technology Operates as a biotech company which develops new therapeutics in the field of inflammation | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norman Bethune Medical University
Norman Bethune Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx GmbH
InflaRx GmbH BiotechnologyHealth Technology Operates as a biotech company which develops new therapeutics in the field of inflammation | Health Technology |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.